跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sambactam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sambactam
Approved
STANDARD
Sambactam
Singapore Pharmawealth Lifesciences, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1d9213d24f5a79d5
Company
Singapore Pharmawealth Lifesciences, Inc.
Type
Standard
Approval Details
Approval Id
1d9213d24f5a79d5
Drug Approval Philippines Name
Sambactam
Product Name
Sambactam
Registration Number
DR-XY46618 (FOR EXPORT ONLY)
Brand Name
Sambactam
Generic Name
Ampicillin (as sodium) + Sulbactam (as sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
500mg/ 250mg
Manufacturer
Singapore Pharmawealth Lifesciences, Inc.
Issuance Date
28 April 2024
Expiry Date
20 June 2029
Pharmacologic Category
Antibacterials (combination of penicillins, including beta-lactamase inhibitors)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1d9213d24f5a79d5
Type
Standard
Back to Philippines FDA Approvals